allogene
Allogene Therapeutics is seeking a Senior Manager to lead cross‑functional project teams within its Portfolio & Program Management group. The role focuses on planning, risk management, and execution of CMC and clinical development activities for one or more pipeline programs, partnering with operations, regulatory, and manufacturing functions.
Headquarters
South San Francisco, California, United States
Company Size
201-500 employees
Founded
2017
Allogene is a clinical-stage biotechnology company developing off-the-shelf AlloCAR T cell therapies using multiplex gene engineering and gene-editing to create allogeneic (ready-made) CAR T candidates. The company pairs a proprietary lymphodepletion approach with scalable, state-of-the-art manufacturing to optimize safety, durability, and broader patient access. Lead programs include cemacabtagene ansegedleucel (cema‑cel) for large B‑cell lymphoma (including frontline DLBCL), ALLO‑316 for renal cell carcinoma, and ALLO‑329 for autoimmune disease, alongside a broader pipeline. Allogene’s platform strategy aims to accelerate delivery of cell therapies by removing patient-specific manufacturing constraints.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for allogene.
15% above the average for this role
CMC Program Manager
Dark Horse Consulting Group Inc
Senior Director, Program & Portfolio Management
Vera Therapeutics, Inc.
Senior Manager/Associate Director, CMC Project Management
8a7883d06ad77017016b233a8d273b44
Senior Project Manager, CMC
Genmab
Director, Site and CMC Program Management
Bristol Myers Squibb
Director, CMC Technical Program Management
Perspective Therapeutics